Table 1.

Characteristics of study participants

Study 1 (intraduodenal glucose at 2 kcal/min)Study 2 (intraduodenal glucose at 3 kcal/min)
Female (n = 9)Male (n = 20)P (no correction)P (corrected for body weight)P (corrected for BMI)Female (n = 10)Male (n = 26)P (no correction)P (corrected for body weight)P (corrected for BMI)
Age (years)25.0 (21.5, 26.0)21.0 (19.0, 27.8)0.1925.0 (21.8, 27.0)23.5 (21.0, 28.0)0.50
Weight (kg)57.1 ± 2.972.9 ± 4.10.00162.3 (54.3, 92.6)73.8 (67.1, 90.1)0.09
BMI (kg/m2)21.5 (20.1, 23.7)22.7 (21.8, 24.2)0.2823.2 (20.2, 31.5)24.3 (22.7, 28.3)0.51
Fasting blood glucose (mmol/L)5.3 ± 0.25.2 ± 0.40.950.320.475.4 ± 0.25.4 ± 0.10.830.930.81
Glucose iAUC0-60min (mmol/L*min)135.7 ± 13.9144.2 ± 10.40.750.350.4499.8 ± 11.7110.4 ± 8.00.470.590.51
Fasting plasma insulin (mU/L)2.9 ± 0.42.4 ± 0.30.450.330.484.7 (2.4, 6.8)5.0 (2.2, 13.3)0.710.180.51
Insulin iAUC0-60min (mU/L*min)1631.3 (1278.4, 2137.9)834.3 (66.24, 1114.1)0.0050.0110.0251738.9 (1345.9, 4772.1)1897.1 (1093.1, 4252.5)0.990.860.85
Fasting plasma GIP (pmol/L)10.9 ± 1.710.3 ± 1.40.810.610.6211.2 (7.5, 16.5)11.5 (6.6, 14.5)0.790.960.95
GIP iAUC0-60min (pmol/L*min)1283.9 ± 121.71352.1 ± 105.30.960.820.781006.2 ± 131.61030.3 ± 68.60.860.740.83
Fasting plasma GLP-1 (pmol/L)19.5 ± 2.023.0 ± 1.50.170.080.0716.7 (14.6, 19.6)15.7 (10.3, 20.7)0.460.610.63
GLP-1 iAUC0-60min (pmol/L*min)524.8 ± 104.6264.3 ± 57.20.0250.0160.039640.5 (280.2, 1002.4)205.5 (87.8, 274.3)0.0110.0120.005
Study 1 (intraduodenal glucose at 2 kcal/min)Study 2 (intraduodenal glucose at 3 kcal/min)
Female (n = 9)Male (n = 20)P (no correction)P (corrected for body weight)P (corrected for BMI)Female (n = 10)Male (n = 26)P (no correction)P (corrected for body weight)P (corrected for BMI)
Age (years)25.0 (21.5, 26.0)21.0 (19.0, 27.8)0.1925.0 (21.8, 27.0)23.5 (21.0, 28.0)0.50
Weight (kg)57.1 ± 2.972.9 ± 4.10.00162.3 (54.3, 92.6)73.8 (67.1, 90.1)0.09
BMI (kg/m2)21.5 (20.1, 23.7)22.7 (21.8, 24.2)0.2823.2 (20.2, 31.5)24.3 (22.7, 28.3)0.51
Fasting blood glucose (mmol/L)5.3 ± 0.25.2 ± 0.40.950.320.475.4 ± 0.25.4 ± 0.10.830.930.81
Glucose iAUC0-60min (mmol/L*min)135.7 ± 13.9144.2 ± 10.40.750.350.4499.8 ± 11.7110.4 ± 8.00.470.590.51
Fasting plasma insulin (mU/L)2.9 ± 0.42.4 ± 0.30.450.330.484.7 (2.4, 6.8)5.0 (2.2, 13.3)0.710.180.51
Insulin iAUC0-60min (mU/L*min)1631.3 (1278.4, 2137.9)834.3 (66.24, 1114.1)0.0050.0110.0251738.9 (1345.9, 4772.1)1897.1 (1093.1, 4252.5)0.990.860.85
Fasting plasma GIP (pmol/L)10.9 ± 1.710.3 ± 1.40.810.610.6211.2 (7.5, 16.5)11.5 (6.6, 14.5)0.790.960.95
GIP iAUC0-60min (pmol/L*min)1283.9 ± 121.71352.1 ± 105.30.960.820.781006.2 ± 131.61030.3 ± 68.60.860.740.83
Fasting plasma GLP-1 (pmol/L)19.5 ± 2.023.0 ± 1.50.170.080.0716.7 (14.6, 19.6)15.7 (10.3, 20.7)0.460.610.63
GLP-1 iAUC0-60min (pmol/L*min)524.8 ± 104.6264.3 ± 57.20.0250.0160.039640.5 (280.2, 1002.4)205.5 (87.8, 274.3)0.0110.0120.005

Abbreviations: BMI, body mass index; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; iAUC0-60min, incremental area under the curve between t = 0-60 minutes.

Normally distributed data are expressed as means ± SEM, while data that are not normally distributed are expressed as median (25% and 75% interquartile range). The bold text used in the table is to emphasis the statistic significance (P < 0.05).

Table 1.

Characteristics of study participants

Study 1 (intraduodenal glucose at 2 kcal/min)Study 2 (intraduodenal glucose at 3 kcal/min)
Female (n = 9)Male (n = 20)P (no correction)P (corrected for body weight)P (corrected for BMI)Female (n = 10)Male (n = 26)P (no correction)P (corrected for body weight)P (corrected for BMI)
Age (years)25.0 (21.5, 26.0)21.0 (19.0, 27.8)0.1925.0 (21.8, 27.0)23.5 (21.0, 28.0)0.50
Weight (kg)57.1 ± 2.972.9 ± 4.10.00162.3 (54.3, 92.6)73.8 (67.1, 90.1)0.09
BMI (kg/m2)21.5 (20.1, 23.7)22.7 (21.8, 24.2)0.2823.2 (20.2, 31.5)24.3 (22.7, 28.3)0.51
Fasting blood glucose (mmol/L)5.3 ± 0.25.2 ± 0.40.950.320.475.4 ± 0.25.4 ± 0.10.830.930.81
Glucose iAUC0-60min (mmol/L*min)135.7 ± 13.9144.2 ± 10.40.750.350.4499.8 ± 11.7110.4 ± 8.00.470.590.51
Fasting plasma insulin (mU/L)2.9 ± 0.42.4 ± 0.30.450.330.484.7 (2.4, 6.8)5.0 (2.2, 13.3)0.710.180.51
Insulin iAUC0-60min (mU/L*min)1631.3 (1278.4, 2137.9)834.3 (66.24, 1114.1)0.0050.0110.0251738.9 (1345.9, 4772.1)1897.1 (1093.1, 4252.5)0.990.860.85
Fasting plasma GIP (pmol/L)10.9 ± 1.710.3 ± 1.40.810.610.6211.2 (7.5, 16.5)11.5 (6.6, 14.5)0.790.960.95
GIP iAUC0-60min (pmol/L*min)1283.9 ± 121.71352.1 ± 105.30.960.820.781006.2 ± 131.61030.3 ± 68.60.860.740.83
Fasting plasma GLP-1 (pmol/L)19.5 ± 2.023.0 ± 1.50.170.080.0716.7 (14.6, 19.6)15.7 (10.3, 20.7)0.460.610.63
GLP-1 iAUC0-60min (pmol/L*min)524.8 ± 104.6264.3 ± 57.20.0250.0160.039640.5 (280.2, 1002.4)205.5 (87.8, 274.3)0.0110.0120.005
Study 1 (intraduodenal glucose at 2 kcal/min)Study 2 (intraduodenal glucose at 3 kcal/min)
Female (n = 9)Male (n = 20)P (no correction)P (corrected for body weight)P (corrected for BMI)Female (n = 10)Male (n = 26)P (no correction)P (corrected for body weight)P (corrected for BMI)
Age (years)25.0 (21.5, 26.0)21.0 (19.0, 27.8)0.1925.0 (21.8, 27.0)23.5 (21.0, 28.0)0.50
Weight (kg)57.1 ± 2.972.9 ± 4.10.00162.3 (54.3, 92.6)73.8 (67.1, 90.1)0.09
BMI (kg/m2)21.5 (20.1, 23.7)22.7 (21.8, 24.2)0.2823.2 (20.2, 31.5)24.3 (22.7, 28.3)0.51
Fasting blood glucose (mmol/L)5.3 ± 0.25.2 ± 0.40.950.320.475.4 ± 0.25.4 ± 0.10.830.930.81
Glucose iAUC0-60min (mmol/L*min)135.7 ± 13.9144.2 ± 10.40.750.350.4499.8 ± 11.7110.4 ± 8.00.470.590.51
Fasting plasma insulin (mU/L)2.9 ± 0.42.4 ± 0.30.450.330.484.7 (2.4, 6.8)5.0 (2.2, 13.3)0.710.180.51
Insulin iAUC0-60min (mU/L*min)1631.3 (1278.4, 2137.9)834.3 (66.24, 1114.1)0.0050.0110.0251738.9 (1345.9, 4772.1)1897.1 (1093.1, 4252.5)0.990.860.85
Fasting plasma GIP (pmol/L)10.9 ± 1.710.3 ± 1.40.810.610.6211.2 (7.5, 16.5)11.5 (6.6, 14.5)0.790.960.95
GIP iAUC0-60min (pmol/L*min)1283.9 ± 121.71352.1 ± 105.30.960.820.781006.2 ± 131.61030.3 ± 68.60.860.740.83
Fasting plasma GLP-1 (pmol/L)19.5 ± 2.023.0 ± 1.50.170.080.0716.7 (14.6, 19.6)15.7 (10.3, 20.7)0.460.610.63
GLP-1 iAUC0-60min (pmol/L*min)524.8 ± 104.6264.3 ± 57.20.0250.0160.039640.5 (280.2, 1002.4)205.5 (87.8, 274.3)0.0110.0120.005

Abbreviations: BMI, body mass index; GIP, glucose-dependent insulinotropic polypeptide; GLP-1, glucagon-like peptide-1; iAUC0-60min, incremental area under the curve between t = 0-60 minutes.

Normally distributed data are expressed as means ± SEM, while data that are not normally distributed are expressed as median (25% and 75% interquartile range). The bold text used in the table is to emphasis the statistic significance (P < 0.05).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close